Cognitive, neuropsychiatric and quality-of-life sequelae in LGI1-antibody disease demonstrates fatigue as the key determinant of wellbeing
Príomhchruthaitheoirí: | , , , , , , , , , |
---|---|
Formáid: | Conference item |
Teanga: | English |
Foilsithe / Cruthaithe: |
Wiley
2020
|